Suppression of antimicrobial protein levels

US10675320B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10675320-B2
Application numberUS-201916242095-A
CountryUS
Kind codeB2
Filing dateJan 8, 2019
Priority dateJan 8, 2018
Publication dateJun 9, 2020
Grant dateJun 9, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Exercise is a stressor that is known to in some cases suppress antimicrobial protein levels, particularly secretory immunoglobulin type A (IgA). Athletes in the midst of in-season training often demonstrate low levels of sIgA and supplements may enhance post exercise mucosal immune function. A study was conducted where three treatments were administered (botanical spray, botanical drops, placebo) at the onset of 30 minutes of 80% V02 max cycle ergometer exercise. Secretory IgA and Human Alpha Defensin were quantified in saliva samples 30 minutes and 90 minutes post exercise. Analysis revealed a significant treatment effect at 30 min (p=0.030) with post hoc testing revealing a difference between the botanical spray and placebo (p=0.027), but by 90 minutes there was no differences by treatment (p=0.758). Based upon this study, it appears that a single dose of the tested botanical can provide enhanced mucosal immune capability for a short time post exercise.

First claim

Opening claim text (preview).

We claim: 1. A method for suppressing upper respiratory tract infection comprising: (a) administrating a dose of a botanical, (b) wherein the botanical is comprised of Bilberry extract, Noni, Milk Thistle, Echinacea, Goldenseal, Shiitake, White Willow bark, Garlic, Grapeseed extract, Walnut hull and leaf, Raspberry, Fumitory, Gentian, Tea Tree oil, Galbanum oil, Lavender oil, and Oregano oil. 2. The method of claim 1 , wherein the dose of botanical is administered prior to exercise. 3. The method of claim 1 , wherein the dose of botanical is administered during exercise. 4. The method of claim 1 , wherein the dose of botanical is administered after exercise. 5. The method of claim 1 , wherein the dose of botanical is administered by spraying in the oral cavity.

Assignees

Inventors

Classifications

  • A61K36/45Primary

    Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry · CPC title

  • Basidiomycota, e.g. Cryptococcus · CPC title

  • Salicaceae (Willow family), e.g. poplar · CPC title

  • Rubiaceae (Madder family) · CPC title

  • Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10675320B2 cover?
Exercise is a stressor that is known to in some cases suppress antimicrobial protein levels, particularly secretory immunoglobulin type A (IgA). Athletes in the midst of in-season training often demonstrate low levels of sIgA and supplements may enhance post exercise mucosal immune function. A study was conducted where three treatments were administered (botanical spray, botanical drops, placeb…
Who is the assignee on this patent?
Univ Louisiana At Lafayette
What technology area does this patent fall under?
Primary CPC classification A61K36/45. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jun 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).